Human Anti-Human CD22 CAR Patent Application EP4130040A1
Summary
The European Patent Office has published patent application EP4130040A1 concerning a fully human anti-human CD22 chimeric antigen receptor and its application, filed by Nanjing Iaso Biotechnology Co., Ltd. The publication date is March 11, 2026.
What changed
European patent application EP4130040A1, titled 'FULLY HUMAN ANTI-HUMAN CD22 CHIMERIC ANTIGEN RECEPTOR AND APPLICATION THEREOF', has been published by the EPO. The application was filed by Nanjing Iaso Biotechnology Co., Ltd. and lists HU, Guang et al. as inventors. The publication date is March 11, 2026.
This publication represents a new patent application filing and does not impose immediate compliance obligations. However, it is relevant for companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in CAR T-cell therapy development, as it may impact intellectual property landscapes and future research or commercialization efforts. Companies should monitor the prosecution of this patent application.
Source document (simplified)
FULLY HUMAN ANTI-HUMAN CD22 CHIMERIC ANTIGEN RECEPTOR AND APPLICATION THEREOF
Publication EP4130040A1 Kind: A1 Mar 11, 2026
Applicants
Nanjing Iaso Biotechnology Co., Ltd.
Inventors
HU, Guang, YANG, Yongkun, NIU, Panpan, MENG, Guangrong, CHENG, Wei, MO, Jialu
IPC Classifications
C07K 16/28 20060101AFI20240322BHEP C12N 15/13 20060101ALI20240322BHEP C07K 19/00 20060101ALI20240322BHEP A61K 39/395 20060101ALI20240322BHEP C12N 15/62 20060101ALI20240322BHEP C12N 5/10 20060101ALI20240322BHEP A61P 35/00 20060101ALI20240322BHEP A61K 39/00 20060101ALI20240322BHEP C07K 14/725 20060101ALI20240322BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.